TREM2 and APOE are dispensable for microglial clearance of dying neurons revealed by in vivo imaging
Authors:
- Anupama RaiARAnupama Rai
- Eyiyemisi C. DamisahEDEyiyemisi C. Damisah
- Robert A. HillRHRobert A. Hill
- Lei TongLTLei Tong
- Jaime GrutzendlerJGJaime Grutzendler
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Cure Alzheimer's Fund
- Center for Scientific Review (R01NS111961)
- Center for Scientific Review (RF1AG058257)
- Center for Scientific Review (R01NS115544)
- Center for Scientific Review (R00NS099469)
- Center for Scientific Review (KL2 TR001862)
- 1Florida Alzheimer's Disease Research Center (P30AG066508)
This publication has 26 references indexed in Scilit:
- TREM2‐dependent microglial function is essential for remyelination and subsequent neuroprotectionGlia, 2023
- TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosisActa Neuropathologica, 2020
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative DiseasesImmunity, 2017
- TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s DiseaseCell, 2017
- Targeted two-photon chemical apoptotic ablation of defined cell types in vivoNature Communications, 2017
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal DystrophyNeuron, 2016
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease ModelCell, 2015
- Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaquesNature Communications, 2015
- Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosaNature Genetics, 2000